论文信息 - Higher-Dose Venetoclax with Measurable Residual Disease-Guided Azacitidine Discontinuation in Newly Diagnosed Patients with Acute Myeloid Leukemia: Phase 2 Hiddav Study - 字舞流文

Higher-Dose Venetoclax with Measurable Residual Disease-Guided Azacitidine Discontinuation in Newly Diagnosed Patients with Acute Myeloid Leukemia: Phase 2 Hiddav Study

C. McMahon | M. Minhajuddin | Amanda C. Winters | D. Pollyea | C. Jordan | Shanshan Pei | Diana Abbott | J. Gutman | Clayton A. Smith | Jennifer Tobin | M. Amaya | J. Schowinsky | Brett M. Stevens | A. Kent | Olivia J. Ondracek | Kelly O'Brien | Angie Falco | Elizabeth Taylor | Constance Brecl | Phuong D. Ho | Connor Sohalski | Jessica Dell-Martin